SAB Biotherapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2022
Total Assets: $50.9M
Liabilities Breakdown FY2022
Total Liabilities: $19.8M
Asset Breakdown
Total Assets: $50.9M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $15.0M | 29.6% |
| Accounts Receivable | $5.6M | 10.9% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $23.3M | 45.7% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $7.1M | 13.9% |
Liabilities Breakdown
Total Liabilities: $19.8M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $3.7M | 18.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $16.2M | 81.5% |